/GABLF
GABLF Stock - GABY Inc.
Healthcare|Medical - PharmaceuticalsOTC
$0.00+45.00%
+$0.00 (+45.00%) • Aug 16
60
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.63
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GABLF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.44
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $21.77M | $25.94M | $3.19M | $7.56M | $1.10M |
| Gross Profit | $10.08M | $9.46M | $-119,211 | $60,395 | $-514,134 |
| Gross Margin | 46.3% | 36.5% | -3.7% | 0.8% | -46.9% |
| Operating Income | $-1,591,436 | $-1,504,078 | $-6,134,085.134 | $-9,503,488.559 | $-4,844,303.723 |
| Net Income | $-29,252,765 | $-9,748,840 | $-10,971,653.753 | $-17,445,404.855 | $-5,668,387.627 |
| Net Margin | -134.4% | -37.6% | -343.6% | -230.6% | -517.6% |
| EPS | $-0.04 | $-0.02 | $-0.05 | $-0.12 | $-0.09 |
Company Overview
GABY Inc., together with its subsidiaries, produces, markets, sells, and retails cannabis-related consumer packaged goods in the United States. The company packages and markets various cannabis products, including flowers, concentrates, pre-rolls, edibles, topicals, tinctures, and other products derived from or infused with cannabis or hemp. It offers its cannabis products under the Mankind, Kind Republic, Lulu's, 2Rise, and Dank Space brand names. The company was formerly known as Gabriella's Kitchen Inc. and changed its name to GABY Inc. in September 2019. GABY Inc. was incorporated in 2003 and is based in Calgary, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GABLFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q2 2023
EPS Surprise History
Q3 21
No data
Q4 21
No data
Q2 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q2 23
No data
Q2 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | Jun 14, 2024 | — | — | — | — |
Q2 2024 | Apr 29, 2024 | — | — | — | — |
Q4 2023 | Nov 30, 2023 | — | — | — | — |
Q3 2023 | Aug 29, 2023 | — | — | — | — |
Q2 2023 | May 30, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 1, 2023 | — | $-0.02 | — | — |
Q4 2022 | Nov 30, 2022 | — | $-0.01 | — | — |
Q3 2022 | Aug 29, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 30, 2022 | — | $0.00 | — | — |
Q2 2022 | May 2, 2022 | — | $-0.01 | — | — |
Q4 2021 | Nov 24, 2021 | — | $-0.00 | — | — |
Q3 2021 | Aug 31, 2021 | — | $-0.00 | — | — |
Q2 2021 | May 26, 2021 | — | $-0.01 | — | — |
Q2 2021 | May 10, 2021 | — | $-0.01 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.00 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.00 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.01 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.02 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.01 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.02 | — | — |
Latest News
Loading news...
Frequently Asked Questions about GABLF
What is GABLF's current stock price?
GABY Inc. (GABLF) is currently trading at $0.00 per share. The stock has moved +45.00% today.
What is the analyst price target for GABLF?
No analyst price targets are currently available for this stock.
What sector is GABY Inc. in?
GABY Inc. operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the OTC exchange.
What is GABLF's market cap?
GABY Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does GABLF pay dividends?
No, GABY Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorATIP
ATI Physical Therapy, Inc.
$0.68
Mkt Cap: $0.0B
AWKNF
Awakn Life Sciences Corp.
$0.07
Mkt Cap: $0.0B
CIMVF
Pideka Group Inc.
$0.01
Mkt Cap: $0.0B
CPYT
CarePayment Technologies, Inc.
$0.00
Mkt Cap: $0.0B
DLTNF
Delta 9 Cannabis Inc.
$0.01
Mkt Cap: $0.0B
EEVVF
Eve & Co Incorporated
$0.08
Mkt Cap: $0.0B
EPWCF
Empower Clinics Inc.
$0.00
Mkt Cap: $0.0B
IWINF
Irwin Naturals Inc.
$0.50
Mkt Cap: $0.0B
RCMW
RCMW Group, Inc.
$0.00
Mkt Cap: $0.0B
RVLWF
Revitalist Lifestyle and Wellness Ltd.
$0.04
Mkt Cap: $0.0B
Explore stocks similar to GABLF for comparison